These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4812764)

  • 1. Proceedings: 4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasms.
    Sklansky BD; Mann-Kaplan RS; Reynolds AF; Rosenblum ML; Walker MD
    Cancer; 1974 Feb; 33(2):460-7. PubMed ID: 4812764
    [No Abstract]   [Full Text] [Related]  

  • 2. Procarbazine hydrochloride in the treatment of brain tumors. Phase 2 study.
    Vasantha Kumar AR; Renaudin J; Wilson CB; Boldrey EB; Enot KJ; Levin VA
    J Neurosurg; 1974 Mar; 40(3):365-71. PubMed ID: 4360491
    [No Abstract]   [Full Text] [Related]  

  • 3. The chemotherapy of brain tumors. Clinical experience with carmustine (BCNU) and vincristine.
    Fewer D; Wilson CB; Boldrey EB; Enot KJ; Powell MR
    JAMA; 1972 Oct; 222(5):549-52. PubMed ID: 4343318
    [No Abstract]   [Full Text] [Related]  

  • 4. 4'-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside (VM-26)--a brief review.
    Goldsmith MA; Carter SK
    Eur J Cancer (1965); 1973 Jul; 9(7):477-82. PubMed ID: 4609765
    [No Abstract]   [Full Text] [Related]  

  • 5. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
    Walker MD; Hurwitz BS
    Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011
    [No Abstract]   [Full Text] [Related]  

  • 6. Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors.
    Rosenblum ML; Reynolds AF; Smith KA; Rumack BH; Walker MD
    J Neurosurg; 1973 Sep; 39(3):306-14. PubMed ID: 4354763
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of primary malignant brain tumors in children.
    Shapiro WR
    Cancer; 1975 Mar; 35(3 suppl):965-72. PubMed ID: 1111955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma.
    Levin VA; Edwards MS; Gutin PH; Vestnys P; Fulton D; Seager M; Wilson CB
    J Neurosurg; 1984 Dec; 61(6):1063-8. PubMed ID: 6502234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of recurrent pediatric posterior fossa tumors.
    Edwards MS; Levin VA; Wilson CB
    Clin Neurosurg; 1983; 30():209-25. PubMed ID: 6667576
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with intrathecal administration of methotrexate in the chemotherapy of malignant intracerebral tumors].
    Romodanov AP; Sosnov IuD; Shcheglov VI
    Vopr Neirokhir; 1975; (1):32-5. PubMed ID: 164086
    [No Abstract]   [Full Text] [Related]  

  • 11. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
    Wilson CB; Boldrey EB; Enot KJ
    Cancer Chemother Rep; 1970 Aug; 54(4):273-81. PubMed ID: 4334089
    [No Abstract]   [Full Text] [Related]  

  • 12. PCNU in the treatment of recurrent medulloblastoma and ependymoma--a POG Study.
    Ragab AH; Burger P; Badnitsky S; Krischer J; Van Eys J
    J Neurooncol; 1986; 3(4):341-2. PubMed ID: 3958779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of brain neoplasms in children].
    Jacobi H
    Z Allgemeinmed; 1974 Sep; 50(25):1092-6. PubMed ID: 4373943
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evolution of chemotherapy for malignant brain tumors].
    Takeshima H; Kuratsu J
    No Shinkei Geka; 2003 Jul; 31(7):725-34. PubMed ID: 12884787
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy of primary brain tumors.
    Levin VA
    Neurol Clin; 1985 Nov; 3(4):855-66. PubMed ID: 3001491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic trials in various hematosarcomas with 4-demethylepipo=dophyllotoxin-beta D thenylidene glucoside (VM 26 or EPT)].
    Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld ; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F
    Nouv Presse Med; 1974 Feb; 3(8):447-51. PubMed ID: 4595690
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy of pediatric posterior fossa tumors.
    Edwards MS; Levin VA; Wilson CB
    Childs Brain; 1980; 7(5):252-60. PubMed ID: 7471913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
    Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
    Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumours.
    European Organization for Research on the Treatment of Cancer, Clinical Screening Group
    Br Med J; 1973 Jul; 3(5873):199-202. PubMed ID: 4578134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors.
    Corden BJ; Strauss LC; Killmond T; Carson BS; Wharam MD; Kumar AJ; Piantadosi S; Robb PA; Phillips PC
    J Neurooncol; 1991 Aug; 11(1):57-63. PubMed ID: 1919647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.